Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Some patients' hair grew back black and white after chemotherapy.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

MK-5108 is safe and shows potential against tumors, especially alone.

Some drugs can cause permanent hair loss, though it's rare.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.